Literature DB >> 31298779

Cyclic Cell-Penetrating Peptides with Single Hydrophobic Groups.

Jian Song1,2, Ziqing Qian1, Ashweta Sahni1, Kuangyu Chen1, Dehua Pei1.   

Abstract

A new family of cyclic cell-penetrating peptides (CPPs) has been discovered; they differ from previously reported cyclic CPPs by containing only a single hydrophobic residue. The optimal CPP structure consists of four arginine residues and a hydrophobic residue with a long alkyl chain (e.g., a decyl group) in a cyclohexapeptide ring. The most active member of this family, CPP 17, has an intrinsic cellular entry efficiency similar to that of cyclic CPP12, the most active CPP reported to date. However, CPP 17 is 2.8 times more active than CPP12 under high serum protein concentrations, presumably because of the lower protein binding. CPP 17 enters the cell primarily by direct translocation at a relatively low concentration (≥5 μm).
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cell-penetrating peptides; cyclic peptides; drug delivery; permeability

Year:  2019        PMID: 31298779      PMCID: PMC6752721          DOI: 10.1002/cbic.201900370

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  17 in total

Review 1.  Cell-penetrating peptides: classes, origin, and current landscape.

Authors:  Francesca Milletti
Journal:  Drug Discov Today       Date:  2012-03-23       Impact factor: 7.851

2.  Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.

Authors:  Saskia A Bode; Marion Thévenin; Chérine Bechara; Sandrine Sagan; Sarah Bregant; Solange Lavielle; Gérard Chassaing; Fabienne Burlina
Journal:  Chem Commun (Camb)       Date:  2012-06-13       Impact factor: 6.222

3.  A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.

Authors:  Falk Duchardt; Mariola Fotin-Mleczek; Heinz Schwarz; Rainer Fischer; Roland Brock
Journal:  Traffic       Date:  2007-07       Impact factor: 6.215

4.  Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters.

Authors:  Deendayal Mandal; Amir Nasrolahi Shirazi; Keykavous Parang
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-15       Impact factor: 15.336

5.  Acylation of octaarginine: Implication to the use of intracellular delivery vectors.

Authors:  Sayaka Katayama; Hisaaki Hirose; Kentaro Takayama; Ikuhiko Nakase; Shiroh Futaki
Journal:  J Control Release       Date:  2010-02-06       Impact factor: 9.776

6.  Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore.

Authors:  Ziqing Qian; Patrick G Dougherty; Dehua Pei
Journal:  Chem Commun (Camb)       Date:  2015-02-07       Impact factor: 6.222

7.  Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells.

Authors:  Hisaaki Hirose; Toshihide Takeuchi; Hiroko Osakada; Sílvia Pujals; Sayaka Katayama; Ikuhiko Nakase; Shouhei Kobayashi; Tokuko Haraguchi; Shiroh Futaki
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

8.  Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs.

Authors:  Ziqing Qian; Tao Liu; Yu-Yu Liu; Roger Briesewitz; Amy M Barrios; Sissy M Jhiang; Dehua Pei
Journal:  ACS Chem Biol       Date:  2012-11-12       Impact factor: 5.100

9.  Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides.

Authors:  Gisela Lättig-Tünnemann; Manuel Prinz; Daniel Hoffmann; Joachim Behlke; Caroline Palm-Apergi; Ingo Morano; Henry D Herce; M Cristina Cardoso
Journal:  Nat Commun       Date:  2011-08-30       Impact factor: 14.919

10.  Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.

Authors:  Ziqing Qian; Jonathan R LaRochelle; Bisheng Jiang; Wenlong Lian; Ryan L Hard; Nicholas G Selner; Rinrada Luechapanichkul; Amy M Barrios; Dehua Pei
Journal:  Biochemistry       Date:  2014-06-11       Impact factor: 3.162

View more
  7 in total

1.  Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.

Authors:  Jin Wen; Hui Liao; Kye Stachowski; Jordan P Hempfling; Ziqing Qian; Chunhua Yuan; Mark P Foster; Dehua Pei
Journal:  Bioorg Med Chem       Date:  2020-08-18       Impact factor: 3.641

2.  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.

Authors:  Robert A Cerulli; Livia Shehaj; Isidora Tosic; Kevin Jiang; Jing Wang; David A Frank; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2020-05-04       Impact factor: 3.641

3.  Stapled Peptide Inhibitors of Autophagy Adapter LC3B.

Authors:  Robert A Cerulli; Livia Shehaj; Hawley Brown; Jennifer Pace; Yang Mei; Joshua A Kritzer
Journal:  Chembiochem       Date:  2020-06-22       Impact factor: 3.164

4.  Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.

Authors:  Marina Buyanova; Ashweta Sahni; Rui Yang; Amar Sarkar; Heba Salim; Dehua Pei
Journal:  Mol Pharm       Date:  2022-04-11       Impact factor: 5.364

Review 5.  Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System.

Authors:  Ildikó Szabó; Mo'ath Yousef; Dóra Soltész; Csaba Bató; Gábor Mező; Zoltán Bánóczi
Journal:  Pharmaceutics       Date:  2022-04-21       Impact factor: 6.525

6.  Mitochondria targeting molecular transporters: synthesis, lipophilic effect, and ionic complex.

Authors:  Akula S N Murthy; Sanket Das; Tejinder Singh; Tae-Wan Kim; Nasim Sepay; Seob Jeon; Jungkyun Im
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

7.  WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with lipid-based transfection reagents.

Authors:  Karidia Konate; Emilie Josse; Milana Tasic; Karima Redjatti; Gudrun Aldrian; Sébastien Deshayes; Prisca Boisguérin; Eric Vivès
Journal:  J Nanobiotechnology       Date:  2021-08-11       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.